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   اﻹهﺪاء
  
 ﻋﻠﻴﻪ اﷲ ﺻﻠﻰ ﻣﺤﻤﺪ ﺳﻴﺪﻧﺎ, واﻟﻤﺮﺳﻠﻴﻦ اﻟﺨﻠﻖ ﺳﻴﺪ إﻟﻰ اﻟﻤﺘﻮاﺿﻊ اﻟﻌﻤﻞ هﺬا أهﺪي
  .وﺳﻠﻢ
 وﻧﻮﻓﻪ ﻋﻠﻲ اﻟﺤﺒﻴﺒﻴﻦ واﻟﺪي واﻟﻰ, ﺣﺮاﺣﺸﺔ ﻣﻮﺳﻰ اﻟﺴﻴﺪ اﻟﻐﺎﻟﻲ زوﺟﻲ إﻟﻰ وأهﺪﻳﻪ آﻤﺎ
 اﻟﻐﺎﻟﻴﺘﻴﻦ اﺑﻨﺘﻲ وإﻟﻰ, ﻣﻮﺳﻰ أم زوﺟﻲ واﻟﺪة وإﻟﻰ, ﺷﻴﺮﻳﻦ اﻟﻐﺎﻟﻴﺔ أﺧﺘﻲ وإﻟﻰ, ﻣﻨﺎﺻﺮة
 ﻓﻠﺴﻄﻴﻦ دوﻟﺔ إﻟﻰ أهﺪﻳﻪ و, اﻟﻌﻠﻢ ﻃﻠﺒﻪ وﻓﻲ اﷲ ﻓﻲ وأﺧﻮاﺗﻲ إﺧﻮﺗﻲ وإﻟﻰ رﻣﻴﺎ و دﻳﺎر
  ,وﺷﻌﺒﺎ وأرﺿﺎ ﺷﻬﺪاء
اﻟﺒﺮﻏﻮﺛﻲ ﺳﻤﻴﺮ اﻟﺪآﺘﻮر وﻣﻌﻠﻤﻲ وﻣﻮﺟﻬﻲ أﺳﺘﺎذي إﻟﻰ وأهﺪﻳﻪ آﻤﺎ
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Abstract 
Bacterial meningitis is a serious infection of the fluid in the spinal cord and the fluid 
that surrounds the brain.   A multiplex assay was devised to provide simultaneous 
detection and discrimination of bacterial and Herpes viruses as pathogenic agents of 
meningitis. 
A DNA extraction method that was suitable for both bacterial and viral meningitis was 
devised; the method was designed to allow concentration of viral  particles by 
ammonium sulfate precipitation, for bacterial pathogens, simultaneous treatment of the 
sample with 2-mercaptoethanol.  The prepared samples were tested for amplifiable 
bacterial or Herpes DNA. Detection was successful when samples were fresh, or when 
DNA was correctly preserved.  Old samples with crude DNA extracts usually produced 
negative PCR results indicating the unstable nature of crude DNA extract and old 
samples. 
The PCR amplification of bacterial DNA was based on previous studies by Barghouthi 
(2009) where the universal method bacterial multiplex (G7) was utilized directly. A 
new multiplex (IM) targeting Human Herpes Viruses 1-6 and 8 was designed in this 
study.  IM multiplex was capable of detecting HHV DNA when extracted from water 
or several dilutions of adulterated CSF (HHV 3/VZV).  Epstein-Barr virus was 
refractory to detection even when two additional primer pairs were introduced, EBV 
was undetectable from DNA and sera of patients with mononucleosis. 
Simultaneous detection of bacterial and VZV virus or CMV was possible when IM was 
combined with G7 in a single multiplex (IMG7).  The results were promising since the 
combined  IMG7 multiplex effectively had detected VZV or CMV DNA extracted 
from CSF.  IMG7 was also efficient in detecting Escherichia coli from adulterated 
CSF.  The results were encouraging with the exception of EBV. 
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Clinically, 230 potential meningitis samples from hospitals in different cities in the 
West Bank, Palestine were collected and tested.  Three samples were reported by the 
hospitals to be viral meningitis. Only one sample was found to be caused by CMV in 
this study, the other two samples were most likely caused by viruses other than HHV 1-
3, 5,6, or 8.  The positive sample was confirmed to contain CMV as shown by DNA 
sequencing and BLAST results determined for the PCR amplicon. 
Although this study did not solve the issue of viral detection, it has brought us closer to 
identifying etiological agents of meningitis; it had shown a new method for DNA 
extraction and the possible mixing of bacterial and viral multiplexes.  In addition, the 
study showed that EBV was refractory to detection by conventional PCR and that 
samples better be processed immediately (bedside testing) to overcome the potential 
loss of viral pathogens in the sample; a result that dictate to hospital directors to move 
in the direction of adopting new technologies and enter the realm of applied research. 
The study has raised questions regarding the detection of over 150 viruses implicated in 
central nervous system pathology including the RNA and DNA known and unknown 
viruses. This study should encourage others to search for solutions for this health 
problem; detection of viruses in general is a health requirement in different settings 
including organ transplants, transfusion, cancer, surgery, immune deficiency cases, and 
others. 
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Introduction: 
Meningitis is a an inflammation of the meninges (1), which form the thin 
protective membrane covering the brain and spinal cord (1, 2).  Meninges have three 
layers; the outermost layer is dura mater, is composed of tough, nonelastic, dense 
connective tissue and adheres to the skull and vertebral column, it is covered on its 
inner most surface by squamous epithelial cells.  The arachnoid is the middle layer 
composed of collagenous and elastic connective tissue, adheres to the dura mater, and 
has trabeculae to connect it to the third inner layer (pia mater).  The pia mater covers 
the brain and the spinal cord. 
 Meningitis may develop in response to a number of causes, usually bacterial or 
viral infection, or can also be caused by other agents.  Bacterial meningitis is the most 
common and notable of central nervous system infections, with high rate of mortality 
and many cases of severe sequelae (1, 3, 4).  Viral meningitis of the central nervous 
system (CNS) (5) include DNA and RNA viruses.  procedures currently used in clinical 
laboratories are microscopic examination of gram stained CSF, this simple method, is 
rapid, accurate, and inexpensive for detecting bacterial meningitis but it is not useful in 
other meningitis (1), Culture is used in detecting bacteria in CSF.  Culturing requires at 
least 8 hours of incubation in culture medium under aerobic and anaerobic conditions, 
and  with several types of media (1, 6, 7).  Moreover, culture frequently remains 
negative, especially if the CSF is taken after initiation of antimicrobial therapy (6, 7).  
Bacteria is an important cause of meningitis and have a high morbidity and mortality 
rates.  The early administration of antibiotics correlates with reduced rate of mortality 
and morbidity.   Antibiotic resistance is a rising problem and increasing with increase 
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use of Empirical therapy without accurate and rapid detection (3, 4, 7).  Antibiotics 
have no role to play in the treatment of viral meningitis, as they neither kill nor stop the 
multiplication of viruses  (8).  The severity of meningitis and its treatment depends on 
the causative virus, this shows the importance of accurate identification and diagnosis 
of the causative agent  of the disease (2). 
Effective treatment of bacterial or viral meningitis often requires the rapid and 
accurate detection and identification of causative in cerebrospinal fluid (CSF) (7).  
Recently; developed polymerase chain reaction (PCR) method using different target 
genes, has made it  possible to detect low number of infectious agents or even 
fragments of their DNA (4, 9, 10, 11, 12).  PCR use of broad-range 16SrRNA gene, 
with subsequent sequencing has been reported, then we use develop system that uses a 
specific-specific multiplex PCR focused on the bacterial and viral micro-organism most 
frequently found in CSF (3, 13).  
1.2 Types of meningitis 
1.2.1. Bacterial meningitis 
Bacterial meningitis is an infection with a high rate of morbidity and mortality, 
this meningitis type is mostly severe, and can cause brain damage, hearing loss, and 
learning disabilities.  Approximately 95% of bacterial meningitis cases are caused by  
Neisseria meningitides, Streptococcus pneumoniae, Streptococcus agalactiae, 
Staphylococcus spp, Escherichia coli, Haemophilus influenzae, or Listeria 
monocytogenes (3, 6, 14).  Bacterial meningitis cause sudden fever, headaches, neck 
stiffness, nausea, vomiting, increased sensitivity to light and confused mental status (9, 
15). 
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Lyme meningitis is the direct result of invasion of the nervous system by 
Borrelia burgdorferi, occurring within the first few months of infection.  It initially 
presents as a chronic basilar meningitis, erythema migrans within the first few weeks 
after injection and still present from 1-6 months later (16, 17).  
1.2.2. Viral meningitis 
Aseptic meningitis is a central nervous system infection.  It is the most common 
type of meningitis that occurs in sporadic outbreaks.  It is generally less severe than 
bacterial meningitis and resolves without specific treatment (16).  Over 100 viruses are 
known to cause viral meningitis in human (17).  These viruses that records under many 
viruses family (Enteroviruses, Arboviral, Mumps, Lymphocytic 
choriomeningitis(LCM) virus and Herpesviruses) (16).  As shown: 
 
1.2.2.1 Enteroviruses 
 Enteroviruses are  the most frequent cause of  life threatening meningitis (15, 
17).  Enteroviruses are small, nonenveloped viruses with +ssRNA genomes  
polyadenylated molecule and one long open reading frame.  Human enteroviruses 
(HEV) types are classified into four species including polioviruses which belongs to 
picornavirus (18), 80% of Enteroviruses cause meningitis.  They are transmitted from 
person to person by fecal-oral or oral-oral routs.  They depend on temperate climate, 
the typical season occurring during June-October (16). 
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1.2.2.2. Arboviral meningitis 
  They are  RNA virus and have the same seasonal pattern as enteroviruses.  
Arbovirviruses are maintained in nature through biological transmission between 
vertebrate host and mosquito vectors.  These viruses cause neurologic signs and 
symptoms of aseptic meningitis.  These types of viruses mostly infect elder people (16).  
1.2.2.3. Mumps 
 It is a ssRNA virus and is a serious causative agent of aseptic meningitis in an 
unimmunized population (16).  Its threat has been greatly reduced due to vaccination 
programs. 
1.2.2.4. Lymphocytic choriomeningitis (LCM). 
  It is a single strand RNA virus and is rarely reported.  This type is transmitted to 
human by contact with rodents or their excretions (2, 16).   
1.2.2.5. Herpes viruses.   
The Herpes group of viruses encompasses double stranded DNA virus with 
linear genomes, and are the most common cause of human meningitis; Human herpes 
simplex virus type-1 (HHV-1) and type-2 (HHV-2), Vericella-Zoster Virus VZV 
(HHV-3), Epstein-Barr virus EBV (HHV-4), Cytomegalovirus CMV (HHV-5) and 
human herpes 6,7, &8 (HHV-6,7, & 8) (13, 16, 17, 19).  
The Human herpes virus-(1&2) is a large virus.  Herpes simplex 1&2 are 
frequently benign but can cause severe disease including skin lesions and cold sores, 
mucous membranes and nervous system infection (20, 21).  The complications of 
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neurological system appear with or without mucocutaneous lesion.  The initial lesions  
appear as clear vesicles containing infectious viruses with a base of red (erythematous) 
lesions at the base of the vesicle (21).  After the primary infection, the virus remains 
latent in the nervous ganglia, where it can reactivate.  This type of disease called 
Mollaret´s disease or meningitis (19, 21).  It is the most recurrent aseptic meningitis 
(19).  HHV 1&2 cause more disease as oral herpes-Cold sores, herpes keratitis, herpes 
whitlow, herpes gladiatorum, Eczema herpeticum, genital herpes, HSV proctitis and 
HSV encephalitis, HSV meningitis (13, 16, 19, 20, 21, 23) its Transmissible by skin-to-
skin contact. 
Varicella Zoster virus (VZV, HHV-3) is known as chicken pox virus.  It is 
characterized with rash (22), skin lesion infection.  If this virus reaches blood 
circulation then it can cause aseptic meningitis with or without typical skin lesions (13, 
16, 17, 19, 20, 21). 
Epstein-Barr virus EBV (HHV-4) causes central nervous system (CNS) 
infection.  This infection occurs in up to 18% of patients with infectious mononucleosis 
and may include encephalitis, meningitis, and other neurological disease especially in 
immunocompetent patients (13, 16, 17, 19, 20, 21, 22, 23).  EBV infection is associated 
with AIDS related CNS lymphoma in HIV-infected patient (16, 17). 
Cytomegalovirus Or CMV(HHV-5) (13, 16, 17, 20, 21), has the largest genome 
of all herpes viruses and appears only to replicate in human cells (21).  CMV 
meningoencephalitis is a disease of congenitally infected newborns and 
immunocompromised individuals.  It plays an important role in organ transplants and in 
patients with advanced HIV infection (17).       
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Human herpes 6 and 7 (exanthum subitum or roseola) infantum are found 
worldwide and found in saliva of the majority of adults and children are infected and 
remain infected for life.  It is latent infection in B and T lymphocytes, which can be 
activated when the cells stimulated to divide (17, 21).  
Human herpes 8 (Kaposi's sarcoma-associated herpes virus), is found in the 
saliva of many AIDS patient.  It infects peripheral blood lymphocytes.        
1.2.3. Fungus. 
Fungal meningitis is much less common than the bacterial and viral meningitis.  
Fungus is rare but can be life threatening, Fungal meningitis rarely occurs in healthy 
people; however,  at higher risk are  those with AIDS, leukemia, or other forms of 
immunodeficiency and immunosuppressed patients.  The most common cause of fungal 
meningitis is Cryptococcus neoformans, Histoplasma capsulatum, Coccidioides 
immitis, Candida albicans, Blastomyces dermatitidis, Aspergillus species and others 
(2). 
1.2.4. Parasitic meningitis 
Parasitic  meningitis is rare but may be fatal.  Naegleria fowleri  (2), 
Toxoplasma gondii and Trypanosoma cruzi are common.  
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1.2.5. Non infectious meningitis 
Non–infectious meningitis may result from cancers, systemic lupus 
erythematosus, some drugs, head injury, and brain surgery.  This type of meningitis is 
non transmissible from patient to another as the name suggests (2). 
1.3. Sign and symptoms 
Clinical manifestation of meningitis include sudden onset of fever, chills, severe 
headaches, nausea, vomiting, neck stiffness, back pain, diffuse paresthesia, mental 
status, increase sensitivity to light and focal neurological deficits (5, 9, 13, 15, 17, 25, 
26). 
1.4. Lab findings 
Normal CSF specimens are color less, whereas bacterial meningitis CSF 
specimens will have a turbid appearance, elevated white blood cell count > 3x107 
cells/l, elevated protein > 1.0g/l, and decreased glucose concentration <2.22 mmol/l. 
Neutrophils more than 70% of the total WBCs in CSF.  In viral meningitis it shows 
mild increase in protein, normal level of glucose and pleocytosis (13, 26, 27). 
1.5. Diagnostic Laboratory tests 
  CSF samples are collected by lumber puncture, need tests are biochemical tests 
such as (glucose and protein concentration), WBC and neutrophils counts, bacterial 
Gram stain, microscopy, and bacterial cultures should be carries out.  Cultures 
frequently remain negative, especially if the CSF samples were taken after 
antimicrobial therapy (1, 4, 6, 7, 9).  Antimicrobial susceptibility testing is done for 
bacteria from CSF to determine their antibiotic spectrum (1, 27).  CSF samples can be 
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seen directly after lumber puncture, but do not give an accurate result, because the 
diagnostic usefulness of the procedures depends on the concentration of bacterium in 
the CSF of patients with bacterial meningitis ranging from 101 to 109 colony forming 
unit (CFU/ml) (1,27), a false negative result may prevail when bacterial concentration 
is low, or if antibiotic had been administered to the patient before CSF collection.  
 Alternative methods of diagnosis of bacterial meningitis include antigen 
detection by Counter immune electrophoresis (CIE), coagglutination (COAG), latex 
agglutination (LA) which  have been  established as rapid and direct detection of 
soluble bacterial antigen in CSF.  These methods are rapid antigen detection test that 
may provide true positive result.  Most CNS bacterial pathogens have been detected by 
antigen-antibody reactions except Streptococcus group B because it has a soluble, type 
specific, capsular, polysaccharide antigen that is released into surrounding body tissues 
and fluid as the bacterium proliferates.  This method can be complicated by non-
specific reactions, cross-reactions and /or low concentration of antigen in clinical 
specimens (1).  
Previous methods cannot improve the diagnoses of meningitis, if the causative 
agent is not a bacterium.  Other ways to diagnose bacterial meningitis and to determine 
the causative agent were sought.  Enzyme immunoassay (EIA) and enzyme-linked 
immunosorbent assay (ELISA), for the detection of bacterial antigens in CSF use 
specific antibodies (1, 28).  The tests can detect bacterial antigens in concentrations as 
low as 0.1 to 5 ng/ml (1).  This method needs several hours to detect the antigen-
antibody complex and  is expensive (1, 28).  Other methods depend on molecular 
component is polymerase chain reaction (PCR).  Recently, developed polymerase chain 
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reaction (PCR) method using different target genes, has made it possible to detect low 
numbers of infectious agent or even fragments of DNA (4, 5, 9, 11, 12).  
 Multiplex PCR use for the detection of nine targeted pathogens has been 
reported to have excellent sensitivity and specificity; specific-Specific multiplex PCR 
focused on a limited number of  bacterial and viral microorganism most frequently 
found in CSF was illustrated (3, 13).  In a most recent study, The Method was applied 
to the detection of bacteria in CSF.  The study showed that the universal method could 
detect bacteria that was missed by culture and bacteria that was obtained after antibiotic 
administration to the patient (29, 30). 
1.6. The universal method. 
Tow study that was developed to take advantage of the multiplex approach, 
probability, and conservative sequences of the 16S rDNA (29, 30), the universal 
method that includes a number of multiplex mixture of primer that contain G5, G7 and 
G11 that can detect and give PCR positive result to any bacterium, G7 has been tested 
and is believed to detect any bacterium,  The Universal Method (Barghouthi 2009) had 
integrated several general primers, PCR amplification, DNA sequencing, and sequence 
alignment (BLAST) in one system designed for the detection and identification of  that 
bacterium, some works have used the 16S rDNA gene as a target for bacterial 
detection.  PCR can be used as a method for the rapid detection of bacteria in clinical 
samples and would be useful in differentiating bacterial from viral infections (29).  
 Strategic application of broad range primers has been found to be superior to 
conventional techniques for detection of bacteria in sterile body fluids (30).  When 
antibiotics were introduced to the patient, culture technique cannot be used since it will 
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have poor sensitivity, there for it would be better to use PCR technique for rapid 
diagnosis of bacterial meningitis (1).  The specificity of broad range universal PCR has 
been satisfactorily improved by further analysis of the PCR products by different 
methods (30).  The assay is valuable for initial screening to confirm or rule out bacterial 
meningitis (29). 
1.7. Treatment. 
Accurate and immediate therapeutic intervention in cases of meningitis may 
prevent undesirable outcomes of the infection.  In addition, accurate determination of 
the absence of bacterial meningitis will prevent administration of ineffective 
antibacterial drugs and allow the continuous search for the true pathogen.  Meningitis is 
a medical emergency requiring immediate diagnosis and immediate treatment.  
Cerebral imaging and repeated lumbar puncture should be considered in patients who 
fail to improve clinically after 48 h of treatment.  Acyclovir and Ganylovire are the  
drugs useful in the treatment of viral infections.  Corticosteroids reduce brain edema, 
intracranial hypertension and meningeal inflammation in experimental models of 
bacterial meningitis (27).  Analgesic drugs may be used to reducing the meningitis 
symptoms (4).   
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1.8. literature Review. 
The most recent study:  The Universal Method Developed by Barghouthi 2009, 
universal method was designed to identify all bacteria.  This method includes a number 
of multiplex mixture of primers (29).   
Universal Method Was successfully applied in the detection of any bacterial 
DNA in CSF samples (30) 
A series of studies have developed species-specific multiplex PCR focused on 
the bacterial and viral microorganisms most frequently found in CSF.  Haemophilus 
influenzae strains that are detected and identified by Real Time PCR (3, 32). 
Streptococcus pneumoniae is an important causative pathogen of acute bacterial 
meningitis, the traditional method need a minimum of 104-105 bacilli/ml to detect it; 
PCR provides a quick detection of Streptococcus pneumoniae (9).  45% of meningitis 
cases involve bacterial loads of less than 105 CFU per/ml (7).  Multiplex PCR applied 
in sero-typing  of Streptococcus pneumoniae directly on clinical sample has sensitivity 
higher than cultural  methods (33).  Multiplex PCR succeeded in detecting, Chlamydia 
pneumoniae DNA in cerebrospinal fluid and in detecting fungi in blood stream 
infection ( 31, 36). 
The use of PCR for rapid diagnosis of microorganisms that cause meningitis has 
the potential to overcome the poor sensitivity and slow growth of pathogens when 
using cultures (35).  In addition to the fact that some pathogens are not culturable, 
diagnosis of viral CNS infection has been revolutionized by the advent of new 
molecular diagnostic technologists such as PCR to amplify viral nucleic acid (17).  The 
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use of multiplex PCR for the diagnosis of CNS diseases has been well evaluated for 
human herpes virus encephalitis (34).  Multiplex PCR used in serotyping and CSF 
based PCR had at least 80% sensitivity and 100% specificity.  For many years many 
studies developed to detect  one or few of the six major human herpes virus (HHSV) 
from cerebrospinal fluid by single tube (3, 16).  
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1.9. Specific Aims and Justification: 
Specific Aims and Justification: Simultaneous  detection of bacteria & HHV1-
6 & 8 in CSF, to reduce the time required for detection, enhance disease treatment, 
management, and minimize administration of empirical antibiotic therapy.  Evaluation 
of clinical CSF bacterial and viral infection is amply justified for treatment and 
epidemiological studies which can be applied upon identification of etiological agents. 
The specific aim of the present study was to develop a single-tube multiplex 
PCR assay for the simultaneous detection of bacteria and human herpes viruses for 
diagnostic application as a multiplex PCR in hospitals with the potential for identifying 
any bacterial agent and most HHVs from CSF- meningitis infections.  The Clinical 
Significance of the single-tube assay is to reduce the time required for detection of 
bacterial or HHV meningitis, in order to enhance treatment and disease management as 
well as minimizing the administration of empirical antibiotic therapy. The study will 
contribute to epidemiological studies and prevention of meningitis that will be a normal 
extension of successful diagnosis of bacterial and Herpes pathogenesis. 
 
1.10. Statement of the Problem 
Molecular method is a new method with some specifications fast, sensitive and 
specific.  This research is designed to test the ability to detect the seven human herpes 
viruses in a single test in addition to any  bacterial pathogen in CSF sample according 
to The Universal Method Developed by Barghouthi 2009, and tested by Barghouthi and 
Zughayyer 2012. in the same reaction. 
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1.11. Hypothesis and Principle: 
A multiplex can be formulated that will allow the simultaneous detection of all 
bacterial pathogens and all or most of the Human Herpes viruses from CSF..   
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Chapter 2 
Materials and methods 
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Materials and methods: 
The method being developed should be sensitive, specific for bacterial and 
Herpes viral infections, easy to apply and interpret, inexpensive, and most importantly 
time saving.  A multiplex that can be formulated as a single-tube test may represent a 
good choice and advancement of CSF diagnosis.  
2.1 Clinical samples and Patient: 
  230 CSF samples obtained from pediatric and adult patients by LB (lumber 
puncture), suspected of suffering from meningitis, were collected over a period of one 
year from hospitals in the west bank; Hebron Governmental Hospital , Yata Hospital,  
Jenin Governmental Hospital, and Nablus Governmental  Hospital.  The clinical CSF 
samples were collected in DNA free sterile screw cap microfuge tubes and stored at -
40˚C.  These samples were tested for bacterial and viral meningitis in the hospitals, 
with conventional method. 
2.1.1 Target pathogens to be detected in this research: 
 Human herpes virus (1&2), Human herpes virus 3 (VZV),  Epstein Barr virus 
(HHV 4), Human herpes virus 5 (CMV), human herpes six and eight (HH6&8), and all 
pathogenic bacteria. The procedure depend on the DNA extraction from the CSF 
samples, do the PCR reaction with thermocycler cycles, and then identify gene 
according to molecular weight on gel electrophoresis.  
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2.2 Primer design: 
Bacterial Universal detection multiplex was as described for G7 multiplex 
(Barghouthi 2009).  Viral primer pairs (Table 2.1) were selected from published DNA 
sequences.  The selected DNA sequence that was targeted for amplification was 
BLAST analyzed against all published sequence to insure its uniqueness and lack of 
cross reactivity.  Similarly, selected primer sequences were analyzed using BLAST.  
The primers were designed to allow their use at a fixed annealing temperature (58-
60˚C).  The primers were also designed to produce a specific size amplicon that did not 
match any other amplicon; each of the potential amplicons should produce a unique 
size  
 
 
 
 
 
 
 
 
 
  
19
 
Table 2.1: Primer pairs of Herpes viruses designed in this study 
Human 
Herpes Virus 
Viral Primer Length Tm PCR product 
size 
HHV1&2 F 5'- CCTCATGATCCTCATCGAGGGCG -3' 
tR 5'- CCGAAACAGCCGGTACACGCG-3' 
23 mer 
21 mer 
61ºC 
60 ºC 
213 
HHV 3 VZ F 5'-GCTCACCCCAAAGGATGACCC-3' 
tR  5'- CGTCGCATACACCGTGTGTACC-3' 
21 
22 
58 ºC 
59 ºC 
679 
HHV4 F 5'-CCACCTCCAGGTGCGCCTAGG-3’ 
tR-5’- TTGGTGCCACCATCTGGCAGC-3’ 
21 
21 
62 ºC 
58 ºC 
346 
        HHV6 A&B F 5’-AGACCGCTGCTGGACGAACTG-3’ 
tR-5’- TTCCTCCGCGGGACCTGGC-3’ 
21 
19 
58 ºC 
60 ºC 
850 
HHV 5 CMV F  5'- GCGTGGAGTCGACGGCCTCC - 3’ 
tR-5’- TGGTGGACATCACGGATACCGAG-3’ 
19 
23 
62 ºC 
59 ºC 
395 
HepB F-  5’- GGACTGGGGACCCTGCACCG-3’ 
tR-5’- GTGGGGGAAAGCCCTACGAACC-3’ 
19 
22 
62 ºC 
60 ºC 
589 
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Additional primer for Epstein-Barr virus 
Table 2.2: Epstein Barr Virus primers. 
Name Sequence 5’3’ TM 
EB-F CCACCTCCAGGTGCGCCTAGG 62˚C,  21-mer , 346bp 
EB-R TTGGTGCCACCATCTGGCAGC 63˚C,  21-mer 
 
BARF QF* GACCGGGGTCCTCACAAACACAG 62˚C, 23-mer , 497bp 
BARF QR CTGCTTGGTGACCTCGGTCTC 60˚C, 21-MER 
 
EB15F GAACAGCTCCTGGACGTTGCG 61˚C, 21-mer,   507bp 
EB15R GTGGCGGCGGCCTTCCTC 64˚C, 18-mer 
(35, 36). 
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Figure 2.1:  A representation of predicted PCR amplicons that may be produced by the 
single multiplex. The predicted sizes are shown.  
2.3 Sample preparation: 
Dry skin from viral lesions was weighed (~ 30mg) and soaked for 10min at 
36˚C in 190µl sterile pure water in a sterile microfuge tube. 
The skin lesion was disrupted and squashed using the plastic pipette tip and 
vigorous vortexing.  A turbid milky suspension was obtained, centrifuged for one 
minute at 5,000 rpm and the supernatant was used in DNA extraction as detailed below. 
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2.4 DNA Extraction from pure stock sample 
Stock sample was collected that contained human herpes viruses; HHV-1 was 
obtained from cold sore volunteer patients showing Herpes oral-lesions, Human herpes 
virus-3 (VZV) was obtained from several children recovering from chicken pox; 
mature dried lesions were collected.  Human herpes virus-4, 6 and 8 (EBV) DNA were 
a gift from Dr. Rania Abu Sir, human herpes virus-5 (CMV) was a gift from Dr. Maysa 
Al-Azza and was obtained as a tissue-culture supernatant.   
DNA extraction from bacterial or viral suspension was optimized; a new 
method was invented for the purpose of satisfying the conditional and simultaneous 
extraction of bacterial and viral DNA.  The new extraction method took into 
consideration possible concentration of both bacteria and viruses.  It was based on 
ammonium sulfate precipitation of viruses followed by centrifugation to ensure the 
concentration of bacteria and the precipitated viruses.  The method is detailed as 
follow:  
To 100µl of viral sample as CSF, or water suspension placed in a labeled sterile 
screw- cap microfuge tube, 190µl of saturated ammonium sulfate (Sigma Chemical 
Company) containing (0.1% 2-mercapto ethanol) were added.  After vigorous mixing, 
and standing for 5 min at ambient room temperature, it was centrifuged ( MIKRO 12-
24) for two minutes at 13,000 rpm.  The pellet (visible or invisible) was dissolved  in 
25µl of 1% sodium dodecyl sulfate (SDS) then diluted with175µl pure sterile water, 
and steamed over a boiling water bath for 15 minutes, centrifuged to remove insoluble 
components, the clear supernatant was collected, used in PCR and stored at -20ºC. 
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2.5 Multiplex Primer preparation. 
A mixture of (10 pmol) of both forward and reverse primer pairs of each target 
virus (Table 2.1) was prepared. .  The Multiplex was prepared by mixing all primer 
pairs (10 pm each) in one mixture; which contained primers for  human herpes virus1 
(HHV-1 / 2),  human herpes virus-3 (VZV), human herpes virus-4 (EBV), human 
herpes virus-5 (CMV), and human herpes virus-6 / 8 (HHV-6&8) The viral multiplex 
was labeled as IM primers.  
Bacterial DNA was detected using G7 multiplex of the Universal method which 
was provided by Dr Barghouthi. 
The single-tube multiplex was prepared by mixing IM and G7 (1:1) ratio which 
produced a solution containg 5 pmol of each viral and bacterial primers (IMG7). 
 
2.6 Specificity testing 
All viruses obtained as DNA or as live viruses from confirmed cases of 
infection (VZV and HHV1/2)  were tested with their specific primer pairs, the viral 
multiplex primer (IM), G7, and the G7-IM mix. 
Bacterial DNA and Escherichia coli DNA was tested with G7 and G7-IM mixture. 
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2.7  PCR reaction preparation 
A final  PCR reaction of  25 µl contained: 
12.5 µl green master mix (Promega, Madison, W1 USA), 11.5 µl water,0.8 µl primer 
mix, 0.2 µl sample DNA.  PCR  parameters were : 
Hot start at 95°C for 3 minutes, followed by 33 cycles of (94°C for 90 sec, 60°C for 
90sec, 72°C for  70 sec), followed by a final extension step at 72°C for 3 minutes.  
 
2.8 Agarose gel electrophoresis. 
Agarose gel buffer, was prepared(250 ml  of Tris-acetate EDTA buffer 
(TAE;48.4 g Tris base, l1.4 ml glacial acetic acid, and 19 ml of 0.5M  EDTA; PH 8.0).  
The buffer was used to prepare 1.5% (w/v) agarose gel and as electrophoretic buffer.  
Ethidium bromide was added (0.5 µg /ml), and the gel was solidification.  The gel was 
electrophoresed for 30 min approximately at 60 volts; 0.6mAmp and visualized under 
UV.  A digital camera with sepia filter, was used to document the gel.  The size of 
DNA bands was determined relative to 100bp-ladder markers  (New England BioLabs). 
 
2.9  DNA Sequencing  
Amplified DNA was purified using DNA purification kit (Nucleo Trap, 
Macherey –Nagel) according to supplier instructions.  The purified product was 
checked on agarose gel and sent for sequencing (DNA sequencing Services, Bethlehem 
University).  The received DNA sequence was analyzed using online BLAST. 
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Chapter 3 
Results 
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Result 
3.1 Assay development: 
This method was developedt to increase the range of PCR identification of all 
bacteria and most human herpes viruses in one PCR test; G7 which contains primers 
that amplify different regions of the bacterial 16SrDNA gene was prepared.  Five 
different primer pairs for human herpes virus (HHV1/2, 3, 4, 5,and 6/8) that can cause 
meningitis (Table 2.1).  Bacterial (G7) and viral (IM mix) primers were all mixed to 
generate a single-tube mix (IMG7), G7 and IM mix were used separately as well. The 
results showed that IMG7 was capable of producing positive results when bacterial 
DNA or relevant viral DNA was added to the PCR reaction.  
  
3.2 Detection of viral DNA using specific primer pairs or multiplexes  
The newly established DNA extraction was useful in the detection of viral DNA 
with specific primer pairs or multiplexes; IM or IMG7. Figure 3.1shows the PCR 
product of HHV1&2 with 213bp (lane1),  human herpes virus 3 ( varicella zoster virus) 
appeared as 679 bp, human herpes virus 5 (cytomegalo virus; CMV) appeared as 395 
bp.  Human herpes virus 4 (Epstein Barr virus A&B) with PCR product 346 could not 
be detected (see discussion). IM multiplex and IMG7 were successful in detecting 
HHV1/2, 3, and 5 but not EB (HHV4) which was refractory to detection throughout the 
study even when pure DNA or clinical serum samples from mononucleosis patients 
(diagnosed positive via serological testing) was utilized several times while changing 
  
27
the DNA extraction method or designing new primers (see discussion). HHV6/8 which 
was obtained later in the study, it was detectable with IM and IMG7 as well.  The DNA 
was obtained as pure samples or as water suspension viral particles in water that was 
extracted as described in methods.  
 
Figure 3.1: M, 100-bp marker ladder; Specific Primer pairs (lanes 1, 2 , 3 and 4); 
231bp amplicon of HHV(1/2) lane1; 679 bp amplicon of VZV/HHV3 lane 2; 395 bp 
amplicon of CMV/ HHV5 lane 3; EBV/HHV4 lane 4 (no amplification);  IM mix 
(lanes 5, 6, 7 and 8); IMG7 mix (lanes 9, 10,11, and 12 ). 
 
3.3 Efficacy of DNA extraction from CSF and detection with Multiplexes IM and 
IMG7 
CSF samples that produced negative results with IM and IMG7 were pooled.  
Viral particles and or Bacteria were then added to the CSF.  The adulterated CSF was 
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used to extract DNA and test for the presence of bacterial and or viral DNA.  The 
results are shown in Figure 3.2. 
 
 
Figure 3.2: Adulterated CSF; VZV water -suspension particles (obtained from healing 
scales of a 3-year old girl) and/or Escherichia coli colonies were mixed with CSF then 
extracted.  VZV 679 bp amplicon was detectable  with IMG7.  Bacterial amplicons 
C 
395
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(usually more than one amplicon) was detected with G7 and IMG7 (panel A). CMV 
particles were used to adulterate CSF, the DNA was extracted and was subjected to 
detection with CMV specific primer pair (S*), IM multiplex, or IMG7 (panel B,C).   
3.4 Sensitivity of PCR detection of Varicella zoster virus in CSF : 
Varicella zoster virus (section 2.3) was diluted by 10-folds serial dilutions in 
CSF (pooled from negative samples). After mixing, the DNA was extracted from each 
dilution (10-105). The extracted DNA was then tested with IM mix.  The results are 
depicted in Figure 3.3.  The virus was detectable after 103 folds dilutions but was not 
detected at higher dilutions.  
 
 
Figure 3.3: Ten-fold serial dilutions of VZV in CSF, a band at 750 bp appeared that is 
longer than the theoretically predicted 679 bp was clearly detected (lanes 10-1, 10-2, 10-3 
, but not at 10-4, and  10-5 . 
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3.5 CSF Clinical Samples  
Clinical CSF samples (230 samples) were collected, kept frozen or were utilized 
as fresh samples for DNA extraction and PCR analysis.  To ensure the reliability of 
results, each sample was tested (screened) separately with both IM and G7 mix; any 
positive sample was retested using the IMG7 mix.  Only one sample showed a positive 
reaction with IM mix, it was suspected for being a CMV meningitis case.  The sample 
was retested with CMV specific primer pair (Figure 3.4).  Which gave a positive result, 
that result was viral meningitis, the PCR product gave positive on 395 kd by used 
multiplex primers (IM primers) and specific CMV primer. 
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Figure 3.4 . Clinical sample showing positive results with CMV specific primer pair (S) 
and with the viral multiplex IM mix, the remaining samples (229 were negative with 
IM) and all 230 samples were negative for bacteria as judged by G7.  
The DNA sample was re-subjected to amplification with CMV primer pair, the 
amplicon was purified using Nucleo Trap binding matrix.  The purified DNA was  
checked on agarose before it was sent for sequencing (Bethlehem University DNA 
sequencing services).  The obtained sequences (Figure 3.5F & R) were aligned against 
available Nucleotide Data Base using online alignment BLAST.  
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Figure 3.5F: Sequencing results with the forward primer of CMV virus applied to the 
Clinical sample amplicon. Showing the sequence and the BLAST results identifying 
Human herpesvirus 5 strain VR1814 (99.17% similarity). 
5’.AGCCCTCATGACCGTGGTGACGCTGTATTTGAGAGCCGTGGAAGTCGTAGGCATCCTG
AAGGGATTGTAAGCCAGGTGAGGATTCTTGAGGGCCCACGCGCGTTCGCGCGGCCAGTT
GGCGGGGTTCATATCCCCGGGCAACGGCGCCGTCGGAGCCCAGGGCGAGTTACCGTTGA
CCGGGGTTTGGGTACCCGCGAAGGTAGGTGTCGGGGCCGGAGCGGGGGCCGTGGAAGG
ATTGACAGGCGTCGGCGTGAGGATGGCAGCGCCGGCGCCAGCAGGAACGTTAACTCCGG
CGCCGAACGTCAACGTCGGTTGCTCGAACTTGTACGCGGTGGTGACGGGCGGTTTGGCG
CTCGTCTCGGTATCCGTGATGTCCACCACCCCTCGGGG3’  
gb|GU179289.1|  Human herpesvirus 5 strain VR1814,  
complete genome Length=235233, Score = 651 bits (352),   
Expect = 0.0;  Identities = 359/362 (99%), Gaps = 2/362(1%),Strand=Plus/Plus 
 
Query  19     ACGCTGTATTTGAG-AGCCGTGGAAGTCGTAGGCATCCTGAAGGGATTGTAAGCCAGGTG  78 
              ||| ||| |||||| ||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  41189  ACGGTGT-TTTGAGAAGCCGTGGAAGTCGTAGGCATCCTGAAGGGATTGTAAGCCAGGTG  41247 
 
Query  79     AGGATTCTTGAGGGCCCACGCGCGTTCGCGCGGCCAGTTGGCGGGGTTCATATCCCCGGG  138 
              |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  41248  AGGATTCTTGAGGGCCCACGCGCGTTCGCGCGGCCAGTTGGCGGGGTTCATATCCCCGGG  41307 
 
Query  139    CAACGGCGCCGTCGGAGCCCAGGGCGAGTTACCGTTGACCGGGGTTTGGGTACCCGCGAA  198 
              |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  41308  CAACGGCGCCGTCGGAGCCCAGGGCGAGTTACCGTTGACCGGGGTTTGGGTACCCGCGAA  41367 
 
Query  199    GGTAGGTGTCGGGGCCGGAGCGGGGGCCGTGGAAGGATTGACAGGCGTCGGCGTGAGGAT  258 
              |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  41368  GGTAGGTGTCGGGGCCGGAGCGGGGGCCGTGGAAGGATTGACAGGCGTCGGCGTGAGGAT  41427 
 
Query  259    GGCAGCGCCGGCGCCAGCAGGAACGTTAACTCCGGCGCCGAACGTCAACGTCGGTTGCTC  318 
              |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  41428  GGCAGCGCCGGCGCCAGCAGGAACGTTAACTCCGGCGCCGAACGTCAACGTCGGTTGCTC  41487 
 
Query  319    GAACTTGTACGCGGTGGTGACGGGCGGTTTGGCGCTCGTCTCGGTATCCGTGATGTCCAC  378 
              |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  41488  GAACTTGTACGCGGTGGTGACGGGCGGTTTGGCGCTCGTCTCGGTATCCGTGATGTCCAC  41547 
 
Query  379    CA  380 
              || 
Sbjct  41548  CA  41549 
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Figure 3.5R: Sequencing results with the reverse primer of CMV virus applied to the 
Clinical sample amplicon. Showing the sequence and the BLAST results identifying 
Human herpesvirus 5 strain VR1814 (99.46% similarity). 
 
5’AGGGCGCCAACCGCCCGTACACCACCGCGTACAAGTTCGAGCAACCGACGTTGACGTTCGGCGCCGGAGTTA
ACGTTCCTGCTGGCGCCGGCGCTGCCATCCTCACGCCGACGCCTGTCAATCCTTCCACGGCCCCCGCTCCGGCCC
CGACACCTACCTTCGCGGGTACCCAAACCCCGGTCAACGGTAACTCGCCCTGGGCTCCGACGGCGCCGTTGCCC
GGGGATATGAACCCCGCCAACTGGCCGCGCGAACGCGCGTGGGCCCTCAAGAATCCTCACCTGGCTTACAATCC
CTTCAGGATGCCTACGACTTCCACGGCTTCTCAAAACACCGTGTCCACCACCCCTCGGAGGCCGTCGACTCCACG
CA-3’ 
gb|GU179289.1|  Human herpesvirus 5 strain VR1814, complete genome 
Length=235233, Score = 669 bits (362), Expect = 0.0, Identities = 367/369 (99%), Gaps 
= 2/369 (1%), Strand=Plus/Minus 
 
Query  4      GCGCC-AACCGCCCGTACACCACCGCGTACAAGTTCGAGCAACCGACGTTGACGTTCGGC  62 
              ||||| |||||||||| ||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  41522  GCGCCAAACCGCCCGT-CACCACCGCGTACAAGTTCGAGCAACCGACGTTGACGTTCGGC  41464 
 
Query  63     GCCGGAGTTAACGTTCCTGCTGGCGCCGGCGCTGCCATCCTCACGCCGACGCCTGTCAAT  122 
              |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  41463  GCCGGAGTTAACGTTCCTGCTGGCGCCGGCGCTGCCATCCTCACGCCGACGCCTGTCAAT  41404 
 
Query  123    CCTTCCACGGCCCCCGCTCCGGCCCCGACACCTACCTTCGCGGGTACCCAAACCCCGGTC  182 
              |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  41403  CCTTCCACGGCCCCCGCTCCGGCCCCGACACCTACCTTCGCGGGTACCCAAACCCCGGTC  41344 
 
Query  183    AACGGTAACTCGCCCTGGGCTCCGACGGCGCCGTTGCCCGGGGATATGAACCCCGCCAAC  242 
              |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  41343  AACGGTAACTCGCCCTGGGCTCCGACGGCGCCGTTGCCCGGGGATATGAACCCCGCCAAC  41284 
 
Query  243    TGGCCGCGCGAACGCGCGTGGGCCCTCAAGAATCCTCACCTGGCTTACAATCCCTTCAGG  302 
              |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  41283  TGGCCGCGCGAACGCGCGTGGGCCCTCAAGAATCCTCACCTGGCTTACAATCCCTTCAGG  41224 
 
Query  303    ATGCCTACGACTTCCACGGCTTCTCAAAACACCGTGTCCACCACCCCTCGGAGGCCGTCG  362 
              |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  41223  ATGCCTACGACTTCCACGGCTTCTCAAAACACCGTGTCCACCACCCCTCGGAGGCCGTCG  41164 
 
Query  363    ACTCCACGC  371 
              ||||||||| 
Sbjct  41163  ACTCCACGC  41155 
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Chapter 4 
Discussion 
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4.1  General aspects of diagnosis: 
It was possible to formulate a few multiplexes (G7 and others; Barghouthi, 
2009)  that allows the detection of any eubacterium based on a common gene shared by 
all eubacteria.  However, viruses are diverse and do not have common genetic features 
that lends itself well to the development of a multiplex for even a group of viruses.  
This is mainly because viruses have small genomes, yet they are distributed among the 
RNA and DNA domains of nucleic acids. 
 In order to have a comprehensive robust assay for detecting any virus, different 
approach must be considered.  Such approach most likely will depend on microarray 
design rather than multiplex, a combination of molecular methods, or development of 
new methods.  Over 150 different viruses have been implicated in the pathogenesis of 
encephalitis; however, due to limitations with diagnostic testing, etiologies of over half 
of the cases remain unknown.  Deficient in traditional laboratory techniques with 
regard to the diagnosis of viral CNS infection have meant that in many patients, a 
clinical diagnosis of viral meningitis is made without supportive laboratory evidence of 
viral etiology.   
Laboratory diagnosis of viral infections of the CNS relied on virus isolation in 
cell culture, and detection of specific antibody production in CSF.  The impact of 
laboratory diagnosis on acute patient management was relatively small because of the 
time taken for virus replication to produce a characteristic cytopathic effect in cell 
culture or for development of a specific antibody response.   
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PCR can be applied to the diagnosis of any disease in which nucleic acid DNA 
and RNA or their expression as mRNA plays a role.  PCR techniques allow for the in 
vitro synthesis of millions of copies of specific gene segment, and allow the rapid 
detection of as few as 1 to 10 copies of target DNA from the original sample.  One of 
the most successful application of CSF PCR is the diagnosis of viral nervous system 
infections.  PCR is ideally suited for identifying fastidious organisms that may be 
difficult or impossible to culture, CSF PCR is previously the gold standard for 
diagnosis of many CNS herpes virus infections (17, 37).  HHV-6 has been associated 
with a wide spectrum of neurological disorders including febrile seizure epilepsy, 
multiple sclerosis, and encephalitis (39). 
Many HHV including HHV1/ 2 , CMV, and HHV 6 possess the characteristic property 
of becoming latent in the host following primary infection (39). 
Enteroviruses may cause up to 90% of aseptic meningitis cases for which a specific      
etiology is identified, Enteroviral meningitis leads to a large number of hospitalizations 
of both children and adults (40).  
 
4.2 Human Herpes Viruses  
In this study, only the Human Herpes Viruses associated with Meningitis were 
targeted for detection (HHV1-6 &8).  The developed multiplex IM was able to 
experimentally detect all targeted viruses except HHV4 (Epstein Barr Virus) for 
unknown reasons. Additional primers listed in table (2.2)  were tested with old and new 
DNA samples as well as with sera from mononucleosis patients, yet the results were 
indifferently negative.  Similar negative PCR results were seen with hepatitis B sera 
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when repeatedly tested with Hepatitis B primer pairs directed to the large S gene and 
two additional nested pairs in a nested DNA reaction (Barghouthi, 2012, unpublished 
data). 
4.3 The development of a simple new method for simultaneous DNA extraction 
from bacteria and viruses 
Simple method such as exposure to high temperature or repetitive freeze-
thawing have been utilized to release nucleic acids from viruses or bacteria.  Nucleic 
acid extraction and purification techniques, such as deposition methods to precipitate 
DNA, this method provides a pure nucleic acid for entry into the amplification reaction, 
along with removal of potential inhibitors of the PCR amplification reaction as well as 
substances that may degrade nucleic acid and reduce yields.  In deposition method used 
in this study; 2-mercaptoethanol along with ammonium sulfate to deposit whole viruses 
and concentrate them since they are largely made of proteins, to isolate the pure DNA, 
then add sodium dodecyl sulfate (SDS 1%) and  then boil the sample to denature the 
proteins and release single strand DNA.  The method was shown to be efficient, simple, 
reliable, time saving, and inexpensive.  It can be used in screening tests similar to the 
IMG7 screening.   
4.4 CSF sample screening with IMG7 
In cases of positive samples; bacteria can be suspected when the PCR contains 
one, two, or multiple bands similar to those shown in Figure 2.1. Herpes viruses are 
suspected when a band of the sizes depicted  in Figure 2.1 appears.  In all cases, 
confirmation of the identity of amplicon source will be made by retesting the sample 
with specific primer pairs, IM multiplex, and G7.  Sequencing of amplicon follows; this 
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was done with the CSF sample that revealed CMV amplicon when amplified with 
multiplexes or specific primer pair (Figures 3.4, 3.5F and 3.5R)   
Although this study did not solve the issue of viral detection, it has brought us closer to 
identifying etiological agents of meningitis; it had shown a new method for DNA 
extraction and the possible mixing of bacterial and viral multiplexes.  In addition, it 
showed that EBV was refractory to detection by conventional PCR and that samples 
better be processed immediately (bedside testing) to overcome the potential loss of viral 
pathogens in the sample; a result that dictate to hospital directors to move in the 
direction of adopting new technologies and enter the realm of applied research.  The 
study has raised questions regarding the detection of over 150 viruses implicated in 
central nervous system pathology including the RNA and DNA known and unknown 
viruses.  This study should encourage others to search for solutions for this health 
problem; detection of viruses in general is a health requirement in different settings 
including organ transplants, transfusion, cancer, surgery, immune deficiency cases, and 
others.  It is strongly recommended that molecular diagnosis of viral pathogens and 
other pathogens be adopted, supported, encouraged, and funded by the State, public, 
and private businesses and firms. 
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Appendixes: 
A:TABLES 
Primer Pair (F&R) for G7 .   
Bacterial 16S  
F3R1 719-740 
F3R2 625 
F3R3 00 
F4Rn1 635 
F4Rn2 530 
F4Rn3 00 
F5R1 1160 
F5R2 1070 
F5R3 470 
F6Rn1 990 
F6Rn2 890 
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F6Rn3 300 
 
 
 
PCR prodct size for each pair of primer. 
 
 
 
 
 
 
  
48
 
 
 
 
 
 
Appendex B: Figures. 
 
Fig (1) 
HHV-1&2 Specific 
primer
 
HHV-1&2 
mix IM 
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Fig (2) 
1&2 the same figure, HHV(1&2), first band with specific primer , the 
second with mix IM primer 
 
 
 
 Fig (3) Clinical cold sore (lane 1, 213bp HHV1/2), lane 5(single 
primer) and 6 (IM), 395bp CMV. 
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          Fig (4)  395 CMV virus. 
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HHV-6 light 
band (850)
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  . اﻟﻜﺸﻒ ﻋﻦ اﻟﺘﻬﺎب اﻟﺴﺤﺎﻳﺎ اﻟﺒﻜﺘﻴﺮﻳﺔ واﻟﻔﻴﺮوﺳﻴﺔ ﻓﻲ اﻟﺴﺎﺋﻞ اﻟﻤﺨﻲ اﻟﺸﻮآﻲRCPﻣﺘﻌﺪدة إﺳﺘﺨﺪام 
  إﻳﻤﺎن ﻣﻨﺎﺻﺮة :إﻋﺪاد
  اﻟﺪآﺘﻮر ﺳﻤﻴﺮ اﻟﺒﺮﻏﻮﺛﻲ:إﺷﺮاف 
  اﻟﻤﻠﺨﺺ
اﻟﻤﻐﻠﻔѧﺔ ( اﻟѧﺴﺤﺎﻳﺎ)اﻷﻏѧﺸﻴﺔ اﻟﺪﻣﺎﻏﻴѧﺔ  ﻟﺘﻬѧﺎبا ، هѧﻮ: MSITIGNINE)ﺑﺎﻟﻼﺗﻴﻨﻴѧﺔ (اﻟﺤﻤѧﺔ اﻟѧﺸﻮآﻴﺔ أو اﻟﺘﻬѧﺎب اﻟѧﺴﺤﺎﻳﺎ 
ﺟﺮﺛﻮﻣﻴѧﺔ، ﻓﻴﺮوﺳѧﻴﺔ، ﻓﻄﺮﻳѧﺔ )ﻋﻠѧﻰ اﻟѧﺮﻏﻢ ﻣѧﻦ أن ﻏﺎﻟﺒﻴѧﺔ أﺳѧﺒﺎب اﻹﺻѧﺎﺑﺔ ﺗﻜѧﻮن ﻋﺪوﻳѧﺔ  .واﻟﺤﺒѧﻞ اﻟѧﺸﻮآﻲ ﻟﻠѧﺪﻣﺎغ
  .، إﻻ أن هﻨﺎك ﻋﻮاﻣﻞ آﻴﻤﻴﺎﺋﻴﺔ وﺧﻼﻳﺎ ورﻣﻴﺔ ﻗﺪ ﺗﺴﺒﺐ ذﻟﻚ أﻳﻀًﺎ(وﻃﻔﻴﻠﻴﺔ
 
ﺒﻜﺘﻴﺮﻳѧﺔ واﻟﻔﻴﺮوﺳѧﻴﺔ ﻋﻠѧﻰ ﺣѧﺪ ﺎﺳѧﺒﺔ ﻻﻟﺘﻬѧﺎب اﻟѧﺴﺤﺎﻳﺎ اﻟوﻟﻘѧﺪ اﺑﺘﻜѧﺮ ﻃﺮﻳﻘѧﺔ اﺳѧﺘﺨﺮاج اﻟﺤﻤѧﺾ اﻟﻨѧﻮوي اﻟﺘѧﻲ آﺎﻧѧﺖ ﻣﻨ
وﻗﺪ ﺻﻤﻢ ﻟﻠﺴﻤﺎح اﻷﺳﻠﻮب ﺗﺮآﻴﺰ اﻟﺠﺴﻴﻤﺎت اﻟﻔﻴﺮوﺳѧﻴﺔ ﻋѧﻦ ﻃﺮﻳѧﻖ اﻟﺘﺮﺳѧﻴﺐ آﺒﺮﻳﺘѧﺎت اﻷﻣﻮﻧﻴѧﻮم، ﻟﻤѧﺴﺒﺒﺎت , ﺳﻮاء
 ﻟﻤﻨѧѧﻊ اﻟﻨѧѧﺸﺎط اﻷﻧﺰﻳﻤѧѧﻲ وﺗﻌﻄﻴѧѧﻞ 2-اﻷﻣѧѧﺮاض اﻟﺒﻜﺘﻴﺮﻳѧѧﺔ، واﻟﻌѧѧﻼج ﻓѧѧﻲ وﻗѧѧﺖ واﺣѧѧﺪ ﻣѧѧﻦ اﻟﻌﻴﻨѧѧﺔ ﻣѧѧﻊ اﻟﻤﺮآﺎﺑﺘﻮﻳﺜѧѧﺎﻧﻮل 
. AND أو اﻟﻬѧﺮﺑﺲ ﻠﻜѧﺸﻒ ﺗﻢ اﺧﺘﺒﺎر اﻟﻌﻴﻨﺎت اﻟﺒﻜﺘﻴﺮﻳѧﺔ اﻟﻤﻌѧﺪة ﻟ . وﻣﻦ ﺛﻢ إذاﺑﻪ ﻟﻠﺮاﺳﺐ وﺑﻌﺪهﺎ ﻏﻠﻲ . RCPﻣﺜﺒﻄﺎت 
اﻟﻌﻴﻨѧﺎت . ANDوآѧﺎن اﻟﻜѧﺸﻒ ﻋѧﻦ ﻋﻴﻨѧﺎت ﻧﺎﺟﺤѧﺔ ﻋﻨѧﺪﻣﺎ آﺎﻧѧﺖ ﺟﺪﻳѧﺪة، أو ﻋﻨѧﺪﻣﺎ ﺗѧﻢ اﻟﺤﻔѧﺎظ ﻋﻠﻴﻬѧﺎ ﺑѧﺸﻜﻞ ﺻѧﺤﻴﺢ 
 .اذا آﺎﻧﺖ اﻟﻌﻴﻨﺔ ﻗﺪﻳﻤﺔاﻟﻘﺪﻳﻤﺔ آﺎﻧﺖ ﺗﻌﻄﻲ ﻧﺘﺎﺋﺞ ﺳﻠﺒﻴﻪ وهﺬا ﻳﺸﻴﺮ إﻟﻰ ﻃﺒﻴﻌﺔ اﻟﺤﻤﺾ اﻟﻨﻮوي اﻟﻐﻴﺮ ﻣﺴﺘﻘﺮﻩ 
اﻟﺘﻲ اﺳﺘﺨﺪم ﻓﻴﻬﺎ ( 9002) اﻟﺒﻜﺘﻴﺮﻳﺔ ﻋﻠﻰ اﻟﺪراﺳﺎت اﻟﺴﺎﺑﻘﺔ اﻟﺘﻲ آﺘﺒﻬﺎ اﻟﺒﺮﻏﻮﺛﻲ AND ﻣﻦ RCPواﺳﺘﻨﺪ اﻟﺘﻀﺨﻴﻢ 
ﺗﺴﺘﻬﺪف اﻹﻧѧﺴﺎن ( MI) اﻟﺠﺪﻳﺪة  اﻟﺒﺎدﻳﺎت ﺗﻢ ﺗﺼﻤﻴﻢ ﻣﺘﻌﺪد . ﻣﺒﺎﺷﺮة( 7G) ﻋﺎﻟﻤﻴﺔ اﻟﺒﻜﺘﻴﺮﻳﺔ  ﻣﻦ ﺑﺎدﻳﺎت أﺳﻠﻮب ﻣﺘﻌﺪد 
 VHH ﻗѧѧﺎدرة ﻋﻠѧѧﻰ اآﺘѧѧﺸﺎف اﻟﺤﻤѧѧﺾ اﻟﻨѧѧﻮوي ﻋﻨѧѧﺪﻣﺎ MIآѧѧﺎن . ﻩ اﻟﺪراﺳѧѧﺔ ﻓѧѧﻲ هѧѧﺬ 8 و 6-1 اﻟﻬѧѧﺮﺑﺲ ﻓﻴﺮوﺳѧѧﺎت 
 ﻓﻴѧﺮوس اﺑѧﺸﺘﺎﻳﻦ VBEآѧﺎن (. VZV/3 VHH) اﻟﻤﻐѧﺸﻮﺷﺔ FSCاﻟﻤﺴﺘﺨﺮﺟﺔ ﻣѧﻦ اﻟﻤﻴѧﺎﻩ أو اﻟﺘﺨﻔﻴﻔѧﺎت اﻟﻌﺪﻳѧﺪ ﻣѧﻦ 
 ﻣѧﻦ ﻻ ﻳﻤﻜѧﻦ اﻟﻜѧﺸﻒ ﻋﻨѧﻪ VBE ﻟﻠﻜﺸﻒ ﺣﺘﻰ ﻋﻨﺪﻣﺎ ﺗѧﻢ إدﺧѧﺎل اﺛﻨѧﻴﻦ ﻣѧﻦ أزواج اﻟﺘﻤﻬﻴѧﺪي إﺿѧﺎﻓﻴﺔ، ﻻ ﻳﺴﺘﺠﻴﺐ ﺑﺎر 
  .ل ﻣﻦ اﻟﻤﺮﺿﻰ اﻟﺬﻳﻦ ﻳﻌﺎﻧﻮن ﻣﻦ ﻋﺪد آﺮﻳﺎت اﻟﺪم اﻟﺒﻴﻀﺎء واﻷﻣﺼﺎAND
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  ﻣﺘﻌѧﺪد اﻟﺒﺎدﻳѧﺎت  ﺟﻨﺒѧﺎ إﻟѧﻰ ﺟﻨѧﺐ ﻣѧﻊ VMC أو VZV اﻟﻔﻴﺮوﺳﺎت اﻟﺒﻜﺘﻴﺮﻳﺔ و  ﻣﻤﻜﻦ وآﺎن اﻟﻜﺸﻒ ﻓﻲ وﻗﺖ واﺣﺪ ﻣﻦ 
 ﻣﺘﻌѧﺪدة ﺑѧﺸﻜﻞ ﻓﻌѧﺎل واﻟﻜѧﺸﻒ 7GMIوآﺎﻧﺖ اﻟﻨﺘﺎﺋﺞ واﻋﺪة ﻣﻨﺬ ﻣﺠﺘﻤﻌѧﺔ (. 7GMI) واﺣﺪ  ﻓﺤﺺ ﻣﺘﻌﺪد ﻓﻲ MI7G
  أﻳﻀﺎ آﻔﺎءة ﻓﻲ اﻟﻜﺸﻒ ﻋﻦ اﻹﺷѧﺮﻳﻜﻴﺔ اﻟﻘﻮﻟﻮﻧﻴѧﺔ 7GMIآﺎن . FSC VMCﺨﺮج ﻣﻦ  اﻟﻤﺴﺘAND أو VZVﻋﻦ 
  .VBEوآﺎﻧﺖ اﻟﻨﺘﺎﺋﺞ ﻣﺸﺠﻌﺔ ﺑﺎﺳﺘﺜﻨﺎء .  اﻟﻤﻐﺸﻮﺷﺔFSC ﻣﻦ ()iloc aihcirehcsE
ﺗѧﻢ .  ﻋﻴﻨﺎت اﻟﺘﻬﺎب اﻟﺴﺤﺎﻳﺎ اﻟﻤﺤﺘﻤﻠﺔ ﻣﻦ اﻟﻤﺴﺘﺸﻔﻴﺎت ﻓѧﻲ ﻣѧﺪن ﻣﺨﺘﻠﻔѧﺔ ﻓѧﻲ اﻟѧﻀﻔﺔ اﻟﻐﺮﺑﻴѧﺔ، ﺗѧﻢ ﺟﻤѧﻊ واﺧﺘﺒﺎرهѧﺎ 032
  ﻋﻴﻨѧﺔ واﺣѧﺪة ﺗѧﻢ اﻟﺘﺄآѧﺪ ﻣﻨﻬѧﺎ ﻓѧﻲ هѧﺬﻩ . اﻟﺘﻬѧﺎب اﻟѧﺴﺤﺎﻳﺎ اﻟﻔﻴﺮوﺳѧﻲ  ﻣﺤﺘﻤﻠѧﺔ ﻴﻨﺎت ﻣѧﻦ اﻟﻤﺴﺘѧﺸﻔﻴﺎت اﻹﺑﻼغ ﻋﻦ ﺛﻼث ﻋ 
-1 VHHﻋﻠﻰ اﻟﻔﻴﺮوﺳﺎت اﻷﺧﺮى ﻣѧﻦ اﻟﻌﻴﻨﺘﻴﻦ اﻷﺧﺮﻳﺎت ﻣﻦ اﻟﻤﻤﻜﻦ أن ﺗﺤﺘﻮي ، وVMCاﻟﺪراﺳﻪ وآﺎﻧﺖ ﺗﺤﻮي 
 TSALBﺪﻳﺪ اﻟﻨﺘﺎﺋﺞ  آﻤﺎ ﻳﺘﻀﺢ ﻣﻦ ﺗﺴﻠﺴﻞ اﻟﺤﻤﺾ اﻟﻨﻮوي وﺗﺤ VMCوأآﺪ اﻟﻌﻴﻨﺔ إﻳﺠﺎﺑﻴﺔ ﻻﺣﺘﻮاء . 8 أو 6،5، 3
  .RCP NOCILPMAل
ﻋﻠﻰ اﻟﺮﻏﻢ ﻣﻦ أن هﺬﻩ اﻟﺪراﺳﺔ ﻟﻢ ﺗﺤﻞ ﻣﺴﺄﻟﺔ اﻟﻜѧﺸﻒ اﻟﻔﻴﺮوﺳѧﻴﺔ، و ذﻟѧﻚ ﻳﺠﻌﻠﻨѧﺎ أﻗѧﺮب إﻟѧﻰ ﺗﺤﺪﻳѧﺪ اﻟﻌﻮاﻣѧﻞ اﻟﻤѧﺴﺒﺒﺔ 
 ﻣﺘﻌѧﺪد اﻟﺒﺎدﻳѧﺎتﻻﻟﺘﻬѧﺎب اﻟѧﺴﺤﺎﻳﺎ، ﺑѧﻞ ﻗѧﺪ أﻇﻬѧﺮت ﻃﺮﻳﻘѧﺔ ﺟﺪﻳѧﺪة ﻻﺳѧﺘﺨﺮاج اﻟﺤﻤѧﺾ اﻟﻨѧﻮوي واﺧѧﺘﻼط ﻣﻤﻜѧﻦ ﻣѧﻦ 
ﻟﻠﺘﻐﻠѧﺐ ﻋﻠѧﻰ اﻟﺨѧﺴﺎﺋﺮ ( اﺧﺘﺒѧﺎر اﻟѧﺴﺮﻳﺮ ) ﺗѧﺘﻢ ﻣﻌﺎﻟﺠﺘﻬѧﺎ ﻋﻠѧﻰ ﻧﺤѧﻮ أﻓѧﻀﻞ اﻟﻌﻴﻨѧﺎت ﻓѧﻮرا واﻟﺘѧﻲ . اﻟﺒﻜﺘﻴﺮﻳﺔ واﻟﻔﻴﺮوﺳѧﻴﺔ 
 وهﻲ اﻟﻨﺘﻴﺠﺔ اﻟﺘﻲ ﺗﻤﻠﻲ ﻋﻠﻰ ﻣѧﺪﻳﺮي اﻟﻤﺴﺘѧﺸﻔﻴﺎت ﻟﻠﺘﺤѧﺮك ﻓѧﻲ ,ﺒﺎت اﻷﻣﺮاض اﻟﻔﻴﺮوﺳﻴﺔ ﻓﻲ اﻟﻌﻴﻨﺔ اﻟﻤﺤﺘﻤﻠﺔ ﻣﻦ ﻣﺴﺒ 
 أآﺜѧﺮ ؤﻻت ﺑﺸﺄن اﻟﻜﺸﻒ ﻋѧﻦ وأﺛﺎرت اﻟﺪراﺳﺔ ﺗﺴﺎ . اﻻﺗﺠﺎﻩ اﻋﺘﻤﺎد ﺗﻜﻨﻮﻟﻮﺟﻴﺎت ﺟﺪﻳﺪة وأدﺧﻞ ﻋﺎﻟﻢ اﻷﺑﺤﺎث اﻟﺘﻄﺒﻴﻘﻴﺔ 
 واﻟﺤﻤﺾ اﻟﻨﻮوي اﻟﻤﻌѧﺮوف وﻓﻴﺮوﺳѧﺎت ﻏﻴѧﺮ ANR ﺑﻤﺎ ﻓﻲ ذﻟﻚ ﻋﻠﻢ اﻷﻣﺮاض  ﻣﻦ ﺗﺴﺒﺐ اﻟﺘﻬﺎب اﻟﺴﺤﺎﻳﺎ 051ﻣﻦ 
  .ﻣﻌﺮوﻓﺔ
هﺬﻩ اﻟﺪراﺳﺔ ﻳﺠﺐ أن ﺗﺸﺠﻊ اﻵﺧﺮﻳﻦ ﻋﻠﻰ اﻟﺒﺤﺚ ﻋﻦ ﺣﻠﻮل ﻟﻬﺬﻩ اﻟﻤﺸﻜﻠﺔ اﻟѧﺼﺤﻴﺔ؛ اﻟﻜѧﺸﻒ ﻋѧﻦ 
، ﻬѧﺎ ﺑﻤﺎ ﻓﻲ ذﻟﻚ ﻋﻤﻠﻴѧﺎت زرع اﻷﻋѧﻀﺎء، وﻧﻘﻠ اﻟﻔﻴﺮوﺳﺎت ﺑﺸﻜﻞ ﻋﺎم هﻮ ﺷﺮط اﻟﺼﺤﺔ ﻓﻲ اﻟﺒﻴﺌﺎت اﻟﻤﺨﺘﻠﻔﺔ 
 .واﻟѧѧѧѧѧѧѧѧѧѧѧѧѧѧѧѧѧѧѧѧﺴﺮﻃﺎن، واﻟﺠﺮاﺣѧѧѧѧѧѧѧѧѧѧѧѧѧѧѧѧѧѧѧѧﺔ، وﺣѧѧѧѧѧѧѧѧѧѧѧѧѧѧѧѧѧѧѧѧﺎﻻت ﻧﻘѧѧѧѧѧѧѧѧѧѧѧѧѧѧѧѧѧѧѧѧﺺ اﻟﻤﻨﺎﻋѧѧѧѧѧѧѧѧѧѧѧѧѧѧѧѧѧѧѧѧﺔ، وﻏﻴﺮهѧѧѧѧѧѧѧѧѧѧѧѧѧѧѧѧѧѧѧѧﺎ 
  
